Skip to main content
  • World Health Organization Global
  • Regions
    World Health Organization WHO Regional websites
    • Africa Africa
    • Americas Americas
    • South-East Asia South-East Asia
    • Europe Europe
    • Eastern Mediterranean Eastern Mediterranean
    • Western Pacific Western Pacific
  • Countries
    World Health Organization Countries, territories and areas in the WHO Western Pacific Region:
    • American Samoa (USA) American Samoa (USA)
    • Australia Australia
    • Brunei Darussalam Brunei Darussalam
    • Cambodia Cambodia
    • China China
    • Cook Islands Cook Islands
    • Fiji Fiji
    • French Polynesia (France) French Polynesia (France)
    • Guam (USA) Guam (USA)
    • Hong Kong SAR (China) Hong Kong SAR (China)
    • Indonesia Indonesia
    • Japan Japan
    • Kiribati Kiribati
    • Lao People's Democratic Republic Lao People's Democratic Republic
    • Macao SAR (China) Macao SAR (China)
    • Malaysia Malaysia
    • Marshall Islands Marshall Islands
    • Micronesia, Federated States of Micronesia, Federated States of
    • Mongolia Mongolia
    • Naoero Naoero
    • New Caledonia (France) New Caledonia (France)
    • New Zealand New Zealand
    • Niue Niue
    • Northern Mariana Islands (USA) Northern Mariana Islands (USA)
    • Palau Palau
    • Papua New Guinea Papua New Guinea
    • Philippines Philippines
    • Pitcairn Islands (UK) Pitcairn Islands (UK)
    • Republic of Korea Republic of Korea
    • Samoa Samoa
    • Singapore Singapore
    • Solomon Islands Solomon Islands
    • Tokelau Tokelau
    • Tonga Tonga
    • Tuvalu Tuvalu
    • Vanuatu Vanuatu
    • Viet Nam Viet Nam
    • Wallis and Futuna (France) Wallis and Futuna (France)
World Health Organization emblem
Western Pacific
Micronesia, Federated States of
  • Home
  • Health topics
  • Our work
  • News
  • Emergencies
  • About us
  1. Home /
  2. News /
  3. Detail Global
29 November 2021
Departmental update

The WHO Chemical Risk Assessment Network Community of Trainers - Webinars on how to design a training in Chemical Risk Assessment

28 November 2021
Departmental update

Looking to the future: The Rockefeller Foundation and WHO identify priorities for global health collaboration

28 November 2021
Highlights

Palliative care interventions in UHC compendium

28 November 2021
Statement

Update on Omicron

26 November 2021
Departmental update

Streets for Life campaign presented with Prince Michael International Road Safety Award

26 November 2021
Statement

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern

26 November 2021
Departmental update

WHO publishes updated guidance on validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus

26 November 2021
Departmental update

Onchocerciasis elimination: achieving NTD road map targets, despite current pandemic challenges

25 November 2021
News release

FIFA supports World Health Organization 16-day campaign to raise awareness on domestic violence

25 November 2021
Departmental update

Gender based violence is a public health issue: using a health systems approach

24 November 2021
Statement

Interim statement on COVID-19 vaccination for children and adolescents

24 November 2021
News release

First meeting of Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

24 November 2021
Departmental update

What’s new in the TB section of the 2021 WHO Model Lists of Essential Medicines

24 November 2021
Departmental update

WHO releases HIV drug resistance report 2021

23 November 2021
Departmental update

Quality assurance of gender-based violence health services in Bangladesh

23 November 2021
Statement

Statement of the Thirtieth Polio IHR Emergency Committee

23 November 2021
News release

WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19

23 November 2021
Joint News Release

WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology

22 November 2021
Departmental update

The Netherlands affirms its position as a leading flexible contributor to WHO

22 November 2021
Departmental update

Gonorrhoea: latest antimicrobial global surveillance results and guidance for vaccine development published

  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
20 January 2022
Departmental update

U.S. EPA and WHO partner to protect public health

16 January 2022
News release

COVAX delivers its 1 billionth COVID-19 vaccine dose

14 January 2022
Statement

WHO recommends two new drugs to treat COVID-19

28 April 2022
Departmental update

Draft Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031

11 January 2022
Statement

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC)

10 January 2022
Statement

Message for World Leprosy Day 2022

11 January 2022
News release

WHO psychological intervention effective in preventing mental disorders among Syrian refugees in Turkey

19 November 2021
Departmental update

International Men’s Day 2021: Enabling a Gender-sensitive Response to End TB

30 December 2021
Departmental update

Together on the road to evidence-informed decision-making for health in the post-pandemic era: new EVIPNet Call for Action

14 December 2021
Departmental update

WHO Global Evidence-to-Policy (E2P) Summit: Three days for the systematic use of evidence-informed decision-making  in health policy and practice

27 December 2021
Departmental update

New Food Safety Community of Practice will help share knowledge and improve practice

23 December 2021
Departmental update

Achieving 70% COVID-19 Immunization Coverage by Mid-2022

22 December 2021
Departmental update

Launch of the WHO Bulletin theme issue on behavioural science

22 December 2021
News release

From vaccines to vaccinations: seventh meeting of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics and Diagnostics

22 December 2021
Statement

Interim statement on booster doses for COVID-19 vaccination

20 December 2021
Highlights

Animation film illustrating the six components required for assessing the development of palliative care

21 December 2021
Departmental update

US FDA approved cabotegravir extended-release – the first long-acting injectable option for HIV pre-exposure prophylaxis

22 December 2021
Medical product alert

Medical Product Alert N°9/2021: Falsified Soliris

21 December 2021
Medical product alert

Medical Product Alert N°8/2021: Falsified Combiart

21 December 2020
Departmental update

Behavioural considerations for acceptance and uptake of COVID-19 vaccines

  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
  • Quick links
    • Newsroom
    • Head of WHO Office
  • Regional links
    • Data
    • Publications
    • Campaigns
    • Careers
  • Help
    • Contact us
    • Cybersecurity
    • Ethics
Micronesia, Federated States of
Privacy legal notice
© 2026
WHO